Towards a RIOK2 chemical probe: cellular potency improvement of a selective 2-(acylamino)pyridine series. Issue 1 (11th November 2020)

• Record Type: Journal Article
• Authors: Wang, Christopher B.; Lorente-Macías, Álvaro; Wells, Carrow; Pickett, Julie E.; Picado, Alfredo; Zuercher, William J.; Axtman, Alison D.
• Is Part Of: RSC medicinal chemistry. Volume 12:Issue 1(2021)
• Page Start: 129
• Page End: 136
• Publication Date: 2020-11-11
• Subjects: Pharmaceutical chemistry -- Periodicals; 615.19005
• DOI: 10.1039/d0md00292e
• Languages: English
• ISSNs: 2632-8682

Abstract

Abstract : Modification of the 2-(acylamino)pyridine scaffold led to the identification of structure–activity relationships that improve RIOK2 cellular potency and maintain its selectivity. Abstract : RIOK2 is an understudied kinase associated with a variety of human cancers including non-small cell lung cancer and glioblastoma. No potent, selective, and cell-active chemical probe currently exists for RIOK2. Such a reagent would expedite re-search into the biological functions of RIOK2 and validate it as a therapeutic target. Herein, we describe the synthesis of naphthyl–pyridine based compounds that have improved cellular activity while maintaining selectivity for RIOK2. While our compounds do not represent RIOK2 chemical probes, they are the best available tool molecules to begin to characterize RIOK2 function in vitro .